✦ LIBER ✦

Natalizumab may be cost effective for MS in Norway

Book ID: 120845003
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 124 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200716160-00006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rotavirus vaccine may be cost effective

Rotavirus vaccine may be cost effective in Australia

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Dengue vaccination may be cost effective

Dengue vaccination may be cost effective in Brazil

✍ Chuang, Yung-Chun; Wang, Shu-Ying; Lin, Yee-Shin; Chen, Hong-Ru; Yeh, Trai-Ming 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

Infliximab may be cost effective in seve

Infliximab may be cost effective in severe, treatment-resistant RA

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Targeted gonorrhoea screening may be cos

Targeted gonorrhoea screening may be cost effective in private practice

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 140 KB

Statins may be cost effective for a wide

Statins may be cost effective for a wide range of subgroups

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Initial endoscopy for dyspepsia may be c

Initial endoscopy for dyspepsia may be cost-effective if unit costs can be reduced

✍ Dr Robert Laheij 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 420 KB